Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Event Oct. 20, 2025, 09:35 UTC AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Files Form 10-Q for Period Ending 2022-08-04 Full text
Register to leave comments News bot Oct. 24, 2025, 9:58 a.m. Company: Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Form Type: 10-Q Filing Date: 2022-08-04 Period of Report: 2022-06-30 Financial Highlights: - Assets: 106707000 - Assets: 109926000 - Liabilities: 22550000 - Liabilities: 25985000 - StockholdersEquity: 84157000
Company: Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Form Type: 10-Q Filing Date: 2022-08-04 Period of Report: 2022-06-30 Financial Highlights: - Assets: 106707000 - Assets: 109926000 - Liabilities: 22550000 - Liabilities: 25985000 - StockholdersEquity: 84157000